Associated Papers
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.
Ansari-Pour N et al.
Blood, 2023
36223594 (PubMed )
Supplement: BLOOD_BLD-2022-017010-mmc2.xlsx › Supplementary_Table_S2
Genetic Testing in CYLD Cutaneous Syndrome: An Update.
Nagy N et al.
The Application of Clinical Genetics, 2021
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
Li YY et al.
Nature Communications, 2017
Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation.
Tantcheva-Poór I et al.
Dermatology (basel, Switzerland), 2016
The cylindromatosis (CYLD) gene and head and neck tumorigenesis.
Verhoeft KR et al.
Cancers of the Head & Neck, 2016
Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P et al.
The American Journal of Dermatopathology, 2013
Select a paper to view details